Navigation Links
Global Leaders Converge for Special Olympics Global Policy Summit
Date:10/4/2007

Government, Health, NGOs, Sports, Academic, and Business Leaders Issue a Call to Action to Improve the Well-being of Individuals with Intellectual

Disabilities

SHANGHAI, China, Oct. 5 /Xinhua-PRNewswire-USNewswire/ -- Leaders across government, health, non-governmental organizations (NGOs), sports, academic and business representing 60 countries gathered today at the 2007 Special Olympics World Summer Games in Shanghai, China, to make a commitment to people throughout the world with intellectual disabilities and their families. Hosted by Special Olympics International, the 2007 Special Olympics World Summer Games Committee, and China Disabled Persons' Federation, "Commitment to Changing Lives: The Global Policy Summit on the Well-being of People with Intellectual Disabilities" is the largest summit event to cast an unprecedented light on the attitudes and needs of people with intellectual disabilities and the challenge they face throughout the world. The event brought together the greatest collection of key global leaders in an effort to educate, inform, and activate about critical issues facing individuals with intellectual disabilities.

(Logo: http://www.newscom.com/cgi-bin/prnh/20040302/LNTU017LOGO )

"The commitment made today by leaders from all sectors will help further the opportunities and rights of people with intellectual disabilities and the work of Special Olympics worldwide," said Timothy P. Shriver, Chairman, Special Olympics International. "Through sport, Special Olympics lays a foundation for community-based development and advancement; collaboration with global leaders extends the reach even further for peace, prosperity and human dignity."

Using the powerful platform of sport, the Global Policy Summit presented five core areas: a global snapshot highlighting key research findings on the attitudes towar
'/>"/>

SOURCE Special Olympics International
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related medicine news :

1. Skin Cancer Research To Go Global
2. Dementia - a global problem
3. Obesity a global problem
4. Suggestions to reduce global heart disease burden
5. Drop in global deaths from measles
6. First global SARS meet opens
7. SARS-Free Taiwan to Mark End Phase of Global Fight
8. Prevent Global Warming by Becoming A Vegetarian
9. India To March Ahead in The Global HealthCare Competition
10. Global Outbreak Of Bird Flu Warning By Chinese Scientist
11. TWO India Doctors Listed in TIME for Contribution to Global Health
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/4/2009)PEMBROKE, Bermuda, Dec. 4 Allied World Assurance,Company Holdings, Ltd (NYSE: AWH ) today announced that Scott Carmilani,President and Chief Executive Officer, and Jack Sennott, Executive Vice,Pres
(Date:12/4/2009)SCOTTSDALE, Ariz., Dec. 4 Healthcare Trust of America, Inc. ("HTA"), a self-managed, non-traded, real estate investment trust, announced the execution of a purchase and sale agreement to acquire a th
(Date:12/4/2009)MADISON HEIGHTS, Mich., Dec. 4 The Editorial Advisory and Securities Review Committee of BetterInvesting Magazine today announced Allergan, Inc. (NYSE: AGN ) as its February 2010 "Stock to Stud
(Date:12/4/2009)WASHINGTON, Dec. 4 While Congress debates whether health care reform would control health care costs, Leapfrog,s purchaser members point to 45 hospitals that lead through example -- delivering the be
(Date:12/4/2009)Late recurrence is a risk for some pediatric cancers, particularly Ewing sarcomas and tumors of the central nervous system, according to a new study published online December 4 in the Journal of the
Breaking Medicine News(10 mins):Health News:Allied World to Present at the 2009 Goldman Sachs U.S. Financial Services Conference 2Health News:Healthcare Trust of America, Inc. Executes Agreement to Acquire a 92,500 Square Foot Medical Office Portfolio Located in Texas and Indiana 2Health News:BetterInvesting Magazine Releases February Stock to Study and Undervalued Stock Choicesfor Investors' Informational and Educational Use 2Health News:The Leapfrog Group Releases Its 2009 Top Hospitals List 2Health News:The Leapfrog Group Releases Its 2009 Top Hospitals List 3
...ts act together to check the perilous trend of twi...artment has suggested a cap on the// embryo, allow...el set in motion by the Human Fertilization and Em... the wrong side of 30. Further IVF clinics w...
...be efficient on animals according to researchers a...ps we can cure HIV infection. This is our hope," s...tario. Clinical trials of the vaccine are expect...e to be careful because we have done the animal, t...
...wn the risk of Alzheimer's disease by reducing inf... recent communiqué. The finding// holds a clue as...in the 1960s and 1970s are at a lesser chance of d...ties of ceasing loss of brain cells, which is a ch...
...ged that AIDS is no more restricted to just risk g...ses are added each day according to statistics wit...bted to be AIDS positive. It is alarming to note t... too has more number of infections being spread th...
... affected only by thalassemia intermedia till Febr... positive.// Initially, blood transfusion wa...rsened, she underwent blood transfusion 10 times l...c kits from the jute baron Govind Sarda's firm; Mo...
...ed by scientists in the US attacks the malaria par...he disease that has kills one million// people a y...veloped by Walter Reed Army Institute of Research ...common, reported the science portal EurekAlert. ...
Other Medicine News:Health News:Thalassemic patient is now HIV positive due to faulty Diagnostic kit… 2
(Date:12/3/2009)NEW YORK, Dec. 3 Guidepoint Global, LLC , a leading primary research firm, today announced the launch of their Sleep Apnea Tracker, a monthly longitudinal data release that monitors and projects tre
(Date:12/3/2009)SUNNYVALE, Calif., Dec. 3 Pharmacyclics, Inc. (Nasdaq: PCYC ), a biopharmaceutical company focused on developing and commercializing innovative small molecule drugs for the treatment of immune media
(Date:12/3/2009)WILMINGTON, Del., Dec. 3 ParagonRx, a Delaware-based company specializing in pharmaceutical risk management and optimal medication use, will host a free webinar on Wednesday, Dec. 9, on the FDA,s dra
Breaking Medicine Technology:Leading Primary Research Firm Guidepoint Global Announces Launch of Sleep Apnea Tracker 2Pharmacyclics to Host Webcast and Conference Call to Discuss Clinical Updates on Its HDAC and BTK Program as Presented at The American Society of Hematology Meeting Dec. 6 & 7 2Natural and Organic Consumers Focus on Health and Wellness Amidst Public Health Concerns 61152 1Natural and Organic Consumers Focus on Health and Wellness Amidst Public Health Concerns 61152 2K State program will give young professionals skills to protect water resources 10693 1High Altitude Mountaineer Will Cross Joins Tender 26apos 3Bs HealthiFeet Team to Raise Awareness On Foot Care for People Battling Diabetes 61149 1High Altitude Mountaineer Will Cross Joins Tender 26apos 3Bs HealthiFeet Team to Raise Awareness On Foot Care for People Battling Diabetes 61149 2High Altitude Mountaineer Will Cross Joins Tender 26apos 3Bs HealthiFeet Team to Raise Awareness On Foot Care for People Battling Diabetes 61149 3High Altitude Mountaineer Will Cross Joins Tender 26apos 3Bs HealthiFeet Team to Raise Awareness On Foot Care for People Battling Diabetes 61149 4
...Host Conference Call at 9:00 a.m. EDT-, MONTVALE,...aq: MEMY ) today announced top-line data from the...ontrolled Phase 2a study,of MEM 1003, a neuronal L...sease. The trial enrolled 183 subjects with mild t...in the United States and included monotherapy,subj...
...N.J. and NEW YORK, Oct. 12 Daiichi Sankyo,Inc. an...d today that they,have signed a contract for a co-...hi Sankyo,s AZOR(TM), a fixed combination of two,a...odipine and the,angiotensin receptor blocker, olme... letter of intent for the co-promotion agreement o...
Other Medicine Technology:Memory Pharmaceuticals Announces Results for Phase 2a Trial of MEM 1003 in Alzheimer's Disease 2Memory Pharmaceuticals Announces Results for Phase 2a Trial of MEM 1003 in Alzheimer's Disease 3Memory Pharmaceuticals Announces Results for Phase 2a Trial of MEM 1003 in Alzheimer's Disease 4Daiichi Sankyo and Forest Laboratories Finalize Contract for Co-Promotion of AZOR(TM) 2Daiichi Sankyo and Forest Laboratories Finalize Contract for Co-Promotion of AZOR(TM) 3Daiichi Sankyo and Forest Laboratories Finalize Contract for Co-Promotion of AZOR(TM) 4
Microalbumin Linearity Control
Total IgE Control
Lyophilized Lipid Control
High-sensitive CRP Control
Medicine Products: